Simple Summary Historically, cancers presenting with their main tumor mass in the ovary
have been classified as ovarian carcinomas (a concise term for epithelial ovarian cancer) …

In January 2019, a group of basic, translational, and clinical investigators and patient
advocates assembled in Miami, Florida, to discuss the current state of the science of low …

TP53 mutations are ubiquitous in high‐grade serous ovarian carcinomas (HGSOC), and the
presence of TP53 mutation discriminates between high and low‐grade serous carcinomas …

There are 5 major histotypes of ovarian carcinomas. Diagnostic typing criteria have evolved
over time, and past cohorts may be misclassified by current standards. Our objective was to …

Background Ovarian carcinomas consist of at least five distinct diseases: high-grade serous,
low-grade serous, clear cell, endometrioid, and mucinous. Biomarker and molecular …

Low grade serous ovarian tumours are a rare and under-characterised histological subtype
of epithelial ovarian tumours, with little known of the molecular drivers and facilitators of …

Low-grade serous carcinoma (LGSC) of the ovary is a rare histological subtype of epithelial
ovarian carcinoma. It has distinct clinical behavior and a specific molecular profile …

Aims To assess the variation in ovarian carcinoma type diagnosis among gynaecological
pathologists from Nordic countries, and whether a rationally designed panel of …

BRAF and KRAS mutations in ovarian serous borderline tumours (OSBTs) and ovarian low‐
grade serous carcinomas (LGSCs) have been previously described. However, whether …

Epithelial ovarian cancer (EOC) is the 6th most common cancer among women in the UK
(2014) and accounts for 4% of all new cases of cancer in females: it has the highest mortality …